2024-09-02 13:18:33
On May 24, 2022, the Bavarian Nordic Vaccine Company in Martinsried, Germany conducted research around the Imvanex vaccine.
Is it still useful to get the mpox (formerly known as “monkeypox”, named after the virus that causes the disease, monkeypox) vaccine? The Superior Authority for Health (HAS), the independent organization that guides French health policy, responded in the affirmative and recommended that people at risk get a shot of the Bavarian Nordic product, which is marketed in Europe as Imvanex, on Monday, September 2.
This target group has not changed since the last outbreak outside Africa in 2022-2023. These include men who have sex with men, trans people who report multiple sexual partners, prostitutes, professionals at sex gathering venues (regardless of the status of those venues), and finally, those who share the same life as those previously mentioned space people.
In total, some 300,000 people are therefore affected by these vaccination recommendations, as the French Ministry of Public Health estimates that the number of men who have sex with multiple partners is around 250,000 and authorities estimate between 250,000 and 300,000 people.
“We are facing a real risk of a pandemicInfectious disease expert Anne-Claude Crémieux insists. This may be one of the rare moments when we are faced with a potential pandemic virus and are able to intervene while the disease remains confined to a limited target population. We must learn from the past. » The Chairman of the HAS Vaccination Technical Committee mentioned in the origin of this opinion that in 2022 and 2023, the first MPOX outbreak outside Africa affected 117 countries around the world and caused approximately 100,000 cases. Popularity.
“The deciding factor is anonymous multiple partnerships”
Today’s health challenge is twofold, as subclade 2b, which broke out two years ago, continues to spread in 13 countries outside Africa, including France – which has reported 126 cases since the beginning of the year, including just one in a woman . The new clade 1b, discovered a year ago in the Democratic Republic of Congo (DRC), is spreading at high rates among its African neighbors and may, like its predecessor, spread around the world.
There is 58.81% left to read in this article. The remainder is reserved for subscribers.
1725451944
#French #health #authorities #recommend #vaccine #boosters #combat #risk #outbreaks